KL₄Surfactant Treatment in Patients With ARDS
Stopped early · Phase 2
Conditions studied: Acute Respiratory Distress Syndrome
In brief
Lung wash with KL₄Surfactant of individual lung segments using a bronchoscope compared to usual care alone consisting primarily of assisted (mechanical) ventilation in patients with acute respiratory distress syndrome(ARDS).
Key facts
- Study ID
- NCT00215553
- Run by
- Windtree Therapeutics
- People needed
- 124
- Starts
- 2001-05-01
- Expected to finish
- 2006-02-01
- Last updated by the study team
- 2018-08-09
Who can join
Age: 16 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Intubated and required mechanical ventilation support
- Met the criteria for ARDS
- Partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) ≤ 200 mmHg and ≥ 60 mmHg within 60 minutes before randomization
- Mean blood pressure was ≥ 60 mmHg immediately before randomization
You may not qualify if…
- Had ARDS due solely to a major trauma
- Was currently participating in another clinical trial or received an experimental drug or device within the previous month
- A woman of childbearing age, unless pregnancy was excluded by a negative urine hCG test or if the subject was surgically incapable of childbearing
- Had a previous episode of ARDS that resolved and then recurred during the current hospitalization
- Had a disease that was sufficiently advanced, in the best judgment of the Principal Investigator, to markedly limit life expectancy to < 6 months
- Was known to have AIDS or symptomatic HIV (CD4 counts <500). Subjects with asymptomatic HIV were not excluded
- Received chemotherapy or radiation within the previous 90 days
- Received an organ transplant other than corneal transplants
- Received, or was currently receiving, immunosuppression therapy within the last 6 months
- Had severe neurological damage or the presence of a disease that was likely to significantly prevent weaning from the ventilator
- Had a best Glasgow Coma Score (GCS) of ≤ 8 or an intracranial pressure ≥ 20 cm H2O prior to the institution of sedatives or paralysis
Where it is running
- Discovery Laboratories, Inc. — Warrington, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.